The Diabetes Data and Hypothesis Hub (D2H2) and the Playbook Partnership Workflow Builder (PPWB): Bioinformatics Tools for Hypothesis Generation via Data Integration
Are you familiar with the bioinformatics tools and databases Enrichr, Harmonizome, BioJupies, and ARCHS4, developed by the Ma’ayan Lab? In this webinar, Dr. Avi Ma’ayan describes two new bioinformatics software tools he and his lab are developing. Learn how these data-integration tools can help analyze various data types to better understand complex diseases, such as diabetes and cancer.
The following tools will be featured:
- Diabetes Data and Hypothesis Hub (D2H2), which combines resources and data sets related to diabetes into one integrative platform; and
- Playbook Partnership Workflow Builder (PPWB), which helps novice users build customizable bioinformatics workflows for generating hypotheses and customizing data analysis and visualization.
The Data Sharing and Reuse Seminar Series is hosted by NIH’s Office of Data Science Strategy. This monthly series highlights new ways of using data to answer today’s most pressing research questions.
Dr. Ma’ayan is a Mount Sinai Endowed Professor in bioinformatics; professor in the department of pharmacological sciences; director of the Mount Sinai Center for Bioinformatics; and a faculty member in the department of artificial intelligence and human health. He holds these positions at the Icahn School of Medicine at Mount Sinai in New York City.
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024